Réunion de concertation pluridisciplinaire moléculaire : soin et recherche ?

Accordingly, in France, the entire clinical research appears to work through a system of funding and legislation conducive to a common care and research goals. It is neither specific to molecular tumor board and nor to precision medicine. Yet, is it still enough to accept patient participation in a clinical trial to care?